These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 23759384

  • 1. Targeted doxorubicin delivery by chitosan-galactosylated modified polymer microbubbles to hepatocarcinoma cells.
    Villa R, Cerroni B, Viganò L, Margheritelli S, Abolafio G, Oddo L, Paradossi G, Zaffaroni N.
    Colloids Surf B Biointerfaces; 2013 Oct 01; 110():434-42. PubMed ID: 23759384
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Galactosylated gelatin nanovectors of doxorubicin inhibit cell proliferation and induce apoptosis in hepatocarcinoma cells.
    Garg M, Madan J, Pandey RS, Sardana S, Katyal A, Chandra R.
    Anticancer Drugs; 2012 Sep 01; 23(8):836-45. PubMed ID: 22407250
    [Abstract] [Full Text] [Related]

  • 4. Polymer shelled microparticles for a targeted doxorubicin delivery in cancer therapy.
    Cerroni B, Chiessi E, Margheritelli S, Oddo L, Paradossi G.
    Biomacromolecules; 2011 Mar 14; 12(3):593-601. PubMed ID: 21235225
    [Abstract] [Full Text] [Related]

  • 5. Galactose-decorated pH-responsive nanogels for hepatoma-targeted delivery of oridonin.
    Duan C, Gao J, Zhang D, Jia L, Liu Y, Zheng D, Liu G, Tian X, Wang F, Zhang Q.
    Biomacromolecules; 2011 Dec 12; 12(12):4335-43. PubMed ID: 22077387
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: Part I--Formulation development and in-vitro characterization.
    Tinkov S, Winter G, Coester C, Bekeredjian R.
    J Control Release; 2010 Apr 02; 143(1):143-50. PubMed ID: 20060861
    [Abstract] [Full Text] [Related]

  • 10. Folate-functionalized unimolecular micelles based on a degradable amphiphilic dendrimer-like star polymer for cancer cell-targeted drug delivery.
    Cao W, Zhou J, Mann A, Wang Y, Zhu L.
    Biomacromolecules; 2011 Jul 11; 12(7):2697-707. PubMed ID: 21619062
    [Abstract] [Full Text] [Related]

  • 11. Synthesis of pH-responsive chitosan nanocapsules for the controlled delivery of doxorubicin.
    Chen CK, Wang Q, Jones CH, Yu Y, Zhang H, Law WC, Lai CK, Zeng Q, Prasad PN, Pfeifer BA, Cheng C.
    Langmuir; 2014 Apr 15; 30(14):4111-9. PubMed ID: 24665861
    [Abstract] [Full Text] [Related]

  • 12. Targeted and synergistic therapy for hepatocellular carcinoma: monosaccharide modified lipid nanoparticles for the co-delivery of doxorubicin and sorafenib.
    Duan W, Liu Y.
    Drug Des Devel Ther; 2018 Apr 15; 12():2149-2161. PubMed ID: 30034219
    [Abstract] [Full Text] [Related]

  • 13. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
    Zou Z, He D, He X, Wang K, Yang X, Qing Z, Zhou Q.
    Langmuir; 2013 Oct 15; 29(41):12804-10. PubMed ID: 24073830
    [Abstract] [Full Text] [Related]

  • 14. Targeting tumor cells through chitosan-folate modified microcapsules loaded with camptothecin.
    Galbiati A, Tabolacci C, Morozzo Della Rocca B, Mattioli P, Beninati S, Paradossi G, Desideri A.
    Bioconjug Chem; 2011 Jun 15; 22(6):1066-72. PubMed ID: 21545180
    [Abstract] [Full Text] [Related]

  • 15. Reductively degradable α-amino acid-based poly(ester amide)-graft-galactose copolymers: facile synthesis, self-assembly, and hepatoma-targeting doxorubicin delivery.
    Lv J, Sun H, Zou Y, Meng F, Dias AA, Hendriks M, Feijen J, Zhong Z.
    Biomater Sci; 2015 Jul 15; 3(7):1134-46. PubMed ID: 26221946
    [Abstract] [Full Text] [Related]

  • 16. Galactosylated nanocrystallites of insoluble anticancer drug for liver-targeting therapy: an in vitro evaluation.
    Wei W, Yue ZG, Qu JB, Yue H, Su ZG, Ma GH.
    Nanomedicine (Lond); 2010 Jun 15; 5(4):589-96. PubMed ID: 20528454
    [Abstract] [Full Text] [Related]

  • 17. Tailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery.
    Du JZ, Du XJ, Mao CQ, Wang J.
    J Am Chem Soc; 2011 Nov 09; 133(44):17560-3. PubMed ID: 21985458
    [Abstract] [Full Text] [Related]

  • 18. Ligand-directed stearic acid grafted chitosan micelles to increase therapeutic efficacy in hepatic cancer.
    Yang Y, Yuan SX, Zhao LH, Wang C, Ni JS, Wang ZG, Lin C, Wu MC, Zhou WP.
    Mol Pharm; 2015 Feb 02; 12(2):644-52. PubMed ID: 25495890
    [Abstract] [Full Text] [Related]

  • 19. Gold nanoparticles conjugated with cisplatin/doxorubicin/capecitabine lower the chemoresistance of hepatocellular carcinoma-derived cancer cells.
    Tomuleasa C, Soritau O, Orza A, Dudea M, Petrushev B, Mosteanu O, Susman S, Florea A, Pall E, Aldea M, Kacso G, Cristea V, Berindan-Neagoe I, Irimie A.
    J Gastrointestin Liver Dis; 2012 Jun 02; 21(2):187-96. PubMed ID: 22720309
    [Abstract] [Full Text] [Related]

  • 20. Liposomes for targeting hepatocellular carcinoma: use of conjugated arabinogalactan as targeting ligand.
    Shah SM, Goel PN, Jain AS, Pathak PO, Padhye SG, Govindarajan S, Ghosh SS, Chaudhari PR, Gude RP, Gopal V, Nagarsenker MS.
    Int J Pharm; 2014 Dec 30; 477(1-2):128-39. PubMed ID: 25311181
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.